These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36482288)
41. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
42. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704 [TBL] [Abstract][Full Text] [Related]
43. Diverse genome-wide DNA methylation alterations in canine hepatocellular tumours. Asari Y; Yamazaki J; Thandar O; Suzuki T; Aoshima K; Takeuchi K; Kinoshita R; Kim S; Hosoya K; Ishizaki T; Kagawa Y; Jelinek J; Yokoyama S; Sasaki N; Ohta H; Nakamura K; Takiguchi M Vet Med Sci; 2023 Sep; 9(5):2006-2014. PubMed ID: 37483163 [TBL] [Abstract][Full Text] [Related]
44. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma. Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967 [TBL] [Abstract][Full Text] [Related]
45. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis. Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723 [TBL] [Abstract][Full Text] [Related]
46. Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis. Sun Y; Li W; Shen S; Yang X; Lu B; Zhang X; Lu P; Shen Y; Ji J J Transl Med; 2019 Nov; 17(1):390. PubMed ID: 31771612 [TBL] [Abstract][Full Text] [Related]
47. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma. Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667 [TBL] [Abstract][Full Text] [Related]
48. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma. Chao J; Zhang XF; Pan QZ; Zhao JJ; Jiang SS; Wang Y; Zhang JH; Xia JC Med Oncol; 2014 Aug; 31(8):102. PubMed ID: 24994609 [TBL] [Abstract][Full Text] [Related]
49. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
50. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma. Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150 [TBL] [Abstract][Full Text] [Related]
51. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509 [TBL] [Abstract][Full Text] [Related]
52. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
53. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
54. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310 [TBL] [Abstract][Full Text] [Related]
55. Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma. Xiong Y; Hu B; Wei L; Jiang D; Zhu M Tumour Biol; 2015 Dec; 36(12):9579-88. PubMed ID: 26141041 [TBL] [Abstract][Full Text] [Related]
56. Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors. Akahoshi K; Tanaka S; Mogushi K; Shimada S; Matsumura S; Akiyama Y; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M J Gastroenterol; 2016 Sep; 51(9):910-22. PubMed ID: 26739296 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma. Fei X; Ma Y; Liu X; Meng Z Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705 [TBL] [Abstract][Full Text] [Related]
58. Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. Wei L; Lian B; Zhang Y; Li W; Gu J; He X; Xie L BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S13. PubMed ID: 24564407 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
60. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]